期刊文献+

PPARγ激动剂对RSV感染的A549细胞TLR3、TNF-α表达的抑制作用 被引量:2

Inhibitory effect of PPARγ agonists on TLR3 and TNF-α expression in human lung epithelial cells infected with respiratory syncytial virus
原文传递
导出
摘要 目的 探讨 A549细胞呼吸道合胞病毒(RSV)感染后Toll样受体3(TLR3)及肿瘤坏死因子-α(TNF-α) mRNA和蛋白表达及PPARγ激动剂15-脱氧前列腺素J2(15d-PGJ2)和罗格列酮的干预作用.方法 建立RSV感染的细胞模型,将传代培养的细胞随机分成6组:15d-PGJ2干预组(A)、罗格列酮干预组(B)、RSV组(C)、PDTC组(D)、GW9662组(E)及对照组(F).各组在培养12、24和48 h后收获上清液和细胞,实时荧光RT-PCR检测TLR3和TNF-α mRNA表达,Western Blot检测TLR3蛋白表达,ELISA法检测上清中TNF-α蛋白水平.结果 与F组相比,各时间点C组TLR3和TNF-α mRNA及蛋白表达均明显升高(均P<0.01);与C组相比,A组、B组和D组TLR3和TNF-α mRNA及蛋白表达均明显降低(均P<0.01).15d-PGJ2和罗格列酮对TLR3和TNF-α mRNA和蛋白表达的抑制作用在12 h最明显;同一时间点A组和B组TLR3和TNF-α mRNA和蛋白的表达量均呈剂量依赖性下降.结论 RSV感染后TLR3和TNF-α mRNA及蛋白表达升高;罗格列酮和15d-PGJ2能以剂量依赖性方式抑制TLR3和TNF-α mRNA和蛋白表达. Objective To study the change of toll-like receptor 3 (TLR3) and tumor necrosis factoralpha (TNF-α) both at the levels of protein and mRNA in human lung epithelial cells (A549) infected with respiratory syncytial virus (RSV) and the effects of peroxisome proliferator-activated receptor γ (PPARγ) agonists Rosiglitazone and 15-deoxy-delta12,14 prostaglandin J2 (15d-PGJ2).Methods RSV inoculation after A549 cells subcultured,then A549 cells were randomly divided into six groups:15d-PGJ2 + RSV group (group A),Rosiglitazone + RSV group (group B),RSV group (group C),PDTC + RSV group (group D),GW9662 + Rosiglitazone + RSV group (group E) and cell control group (group F).Cells were harvested after incubated for 12 h,24 h and 48 h respectively.The expression of TLR3 and TNF-α at mRNA was determined by real-time RT-PCR,and the protein level of TLR3 and TNF-α was determined by Western Blot and ELISA respectively.Results The expression of TLR3 and TNF-α at mRNA and protein at virous time in group C were significantly higher than those of group F (all P 〈 0.01).While,the expression of TLR3 and TNF-α mRNA and protein in group A,B and D were significantly lower than than those of group C (all P 〈 0.01).15d-PGJ2 and Rosiglitazone had the strongest effect to inhibit the expression of TLR3 and TNF-αmRNA and protein at 12 h and the expression of TLR3 and TNF-α mRNA and protein decreased as the increasing dose of 15d-PGJ2 and Rosiglitazone.Conclusion RSV infection induces increased expression of TLR3 and TNF-α mRNA and protein,which can be inhibited by Rosiglitazone and 15d-PGJ2 in a dose-dependent manner.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2014年第5期342-345,共4页 Chinese Journal of Experimental and Clinical Virology
基金 浙江省自然科学基金(Y2090932) 温州市科技计划对外合作交流基金(H20080054)
关键词 PPARγ/激动剂 呼吸道合胞病毒 感染 受体 TOLL 肿瘤坏死因子 PPARγ/agonists Respiratory syncytiall virus Infection Receptors, Toll-like Tumor necrosis factor
  • 相关文献

参考文献7

  • 1Yusuf S,Piedimonte G,Auais A,et al.The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus.Epidemiol Infect,2007,135:1077-1090.
  • 2Kawai T,Akira S.Toll-like receptor and RIG-I-like receptor signaling.Ann N Y Acad Sci,2008,1143:1-20.
  • 3Zhou S,Kurt-Jones EA,Mandell L,et al.MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.Eur J Immunol,2005,35:822-830.
  • 4Wakui Y,Inoue J,Ueno Y,et al.Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptorgamma ligand,rosiglitazone.Biochem Biophys Res Commun,2010,396:508-514.
  • 5万春杰,董琳,林洁,陈小芳.PPARγ激动剂抗呼吸道合胞病毒感染作用的体外研究[J].中华实验和临床病毒学杂志,2011,25(6):480-482. 被引量:5
  • 6Kim SH,Hong JH,Lee YC.Ursolic acid,a potential PPARgamma agonist,suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5,IL-13,and IL-17 in a mouse model of allergic asthma.Eur J Pharmacol,2013,701:131-143.
  • 7Reddy AT,Lakshmi SP,Kleinhenz JM,et al.Endothelial cell peroxisome proliferator-activated receptor gamma reduces endotoxemic pulmonary inflammation and injury.J Immunol,2012,189:5411-5420.

二级参考文献6

  • 1Perez-Yarza EG, Moreno A, Lazaro P, et al. The association between respiratory syncytial virus infection and the development of childhood asthma : a systematic review of the literature. Pediatr Infect Dis J,2007,26:733-739.
  • 2Lusebrink J,Schildgen V, Schildgen O. Novel therapies for an old virus:treatment of RSV infections in the 21st Century. Expert Rev Anti Infect Ther,2009,7 : 1125-1129.
  • 3Potula R, Ramirez SH, Knipe B, et al. Peroxisome proliferator- activated receptor-gamma activation suppresses HIV-I replication in an animal model of encephalitis. AIDS,2008, Aug 20,22 : 1539-1549.
  • 4Arnold R, Ksnig W. Peroxisome proliferator-activated receptor agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial ceils. Virology,2006,350 : 335-346.
  • 5Lanari M,Silvestri M, Rossi GA. Respiratory syncytial virus risk factors in late preterm infants. J Matern Fetal Neonatal Med, 2009,22 : 102-107.
  • 6Arnold R, Ktinig W. Peroxisome-proliferator-activated receptor-T agonists inhibit the release of proinflammatory cytokines from RSV -infected epithelial cells. Virology, 2006,346:427 -439.

共引文献4

同被引文献19

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部